Randomization aims to prevent systematic differences between groups by evenly distributing both known and unknown factors that could influence the outcome. By assigning participants to intervention or control by chance, it guards against selection bias—decisions about who gets which treatment can’t be manipulated by researchers or participants—and against confounding factors that could distort comparisons. With prognostic factors balanced on average, observed differences in outcomes are more likely to reflect the effect of the intervention itself. This also supports the validity of the statistical analyses that assume comparable groups. Remember, randomization does not guarantee equal numbers in each arm, nor does it guarantee a favorable result; it just creates a fair comparison so the treatment effect can be estimated without bias. Allocation concealment helps maintain this integrity by preventing foreknowledge of assignments.

From a utilitarian view, the focus is on the overall welfare produced by an action or technology. Reproductive technologies can increase happiness and well-being by expanding the ability to have children, reducing infertility distress, and enabling families to form in cases where biology or circumstances would otherwise block it. If the benefits for prospective parents, children, and society at large outweigh the harms—such as medical risks or concerns about surrogate welfare—and the risk to birth outcomes is low, the technology is seen as producing a net gain in welfare. In that light, reproductive technology would generally be viewed as capable of yielding net gains in IVF and surrogacy with relatively low risk to birth defects, rather than banning them or disregarding participants’ happiness.

The main idea here is that a surrogate agreement can be legally binding when the state allows it and the proper procedures are followed. In New Jersey, the court’s ruling that the surrogate agreement is binding means it is enforceable and creates legitimate obligations for both parties. Once a court recognizes the arrangement as binding, the intended parents are acknowledged as the legal parents, and the surrogate’s rights and responsibilities are set within the contract and the court’s oversight. This isnures that the terms—such as parentage transfer and the parties’ financial and other agreed obligations—must be honored. If a contract were invalid or void, it would not be recognized or enforceable at all. If it were merely described as enforceable without the binding designation, it might suggest it could be upheld in court but without the firm sense that the court has established a binding relationship and obligations upon all parties. The binding status emphasizes that the court will uphold the agreement as a valid contract and ensure the agreed terms are carried out.

Justice as fairness is the idea this item is getting at. In contract theory for human research, the emphasis is on treating all participants as moral equals and ensuring that the burdens and benefits of research are distributed without letting social status influence who bears risk or who gains potential benefits. This mirrors the notion of a social contract among equals, where rules are designed so that no group is advantaged or disadvantaged merely by their position in society. Why this fits best: justice focuses on equality and non-discrimination in who participates, who bears risk, and who receives benefits. It underpins fair subject selection, equal respect for persons, and protection against exploitation, all regardless of status. By contrast, autonomy centers on respecting individuals’ decision-making capacity and obtaining informed consent; beneficence is about promoting good and maximizing benefits; nonmaleficence is about avoiding harm. While those principles are essential, they do not by themselves require or guarantee equal treatment across social status in the way contract-theory-based justice does.